NCT06524167

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

A Real-world Study of Adjuvant Radiotherapy in High Recurrence Risk Locally Advanced Thyroid Cancer

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 80 (estimated)
• Sponsor: Fudan University · Academic / Other
• Sex: All
• Age: 14 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study is a real-world study to observe the role of adjuvant radiotherapy in locally advanced recurrent high-risk thyroid cancer. The study included thyroid cancer that requires adjuvant radiotherapy to increase local control rate, excluding undifferentiated cancer. Local-regional recurrence free survival is the primary endpoint of the study.

Conditions

• Thyroid Cancer

Interventions

Type	Name	Description
RADIATION	adjuvant radiotherapy	The patients would receive external radiation therapy within 6 weeks after surgery, using intensity-modulated radiation therapy (IMRT) or volume modulated radiation therapy (VMAT) techniques. 6MV-X-ray irradiation. Conventional segmented irradiation is used, once a day, five times a week, with a segmented dose of 2Gy per dose.

Timeline

• Start date: 2024-07-02
• Primary completion: 2031-06-30
• Completion: 2031-06-30
• First posted: 2024-07-29
• Last updated: 2026-02-27

Locations

1 site across 1 country: China